Medipost Co Ltd
KOSDAQ:078160
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7 570
23 900
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| KR |
M
|
Medipost Co Ltd
KOSDAQ:078160
|
934.1B KRW |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
93.3B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
60.5B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
72.3B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.9B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
21.9B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.4B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20.3B USD |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
14B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR |
Loading...
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
10.9B AUD |
Loading...
|
Market Distribution
| Min | -163 055.6% |
| 30th Percentile | -2.2% |
| Median | 2.7% |
| 70th Percentile | 6.8% |
| Max | 22 874.8% |
Other Profitability Ratios
Medipost Co Ltd
Glance View
Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2005-07-29. The firm mainly operates cord blood banks. Its cord blood banks consist of public cord blood bank, which provides resource to anyone who may need to undergo hematopoietic stem cell transplantation (HSCT) as a result of blood-related diseases, such as leukemia or aplastic anemia, as well as family cord blood bank, which provides services for storing newborn’s cord blood exclusively for family’s use. The company also involves in the provision of stem cell drugs, which are used for recovery of knee articular cartilage and others, distribution of healthcare food and natural cosmetics, as well as provision of healthcare services.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Medipost Co Ltd is -89%, which is below its 3-year median of -49.9%.
Over the last 3 years, Medipost Co Ltd’s Operating Margin has decreased from -25.4% to -89%. During this period, it reached a low of -102.6% on Mar 31, 2025 and a high of 5% on Mar 31, 2024.